Chronic obstructive pulmonary disease (COPD) is a serious public health problem, due
largely to cigarette smoking. COPD is now the fourth-leading cause of death in the United …

The presentation of chronic obstructive pulmonary disease (COPD) usually is insidious, and
many patients are undiagnosed until the disease is far advanced. Therefore, the early use of …

Background: This document provides clinical recommendations for the pharmacologic
treatment of chronic obstructive pulmonary disease (COPD). It represents a collaborative …

Chronic Obstructive Pulmonary Disease (COPD) is the most common lung disease in the
world1. It accounts for the highest rate of hospital admissions among major chronic illnesses …

Pharmacologic treatment of chronic obstructive pulmonary disease (COPD) has evolved
considerably during the past several decades. Initial treatment of the disease was …

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable but usually
progressive obstructive lung disease most often associated with tobacco smoking in …

Classical belief is that only smoking cessation, and not pharmacotherapy, beneficially affect
disease progression in chronic obstructive pulmonary disease (COPD). In recent years, new …

Pharmacology of bronchodilators used in the treatment of COPD Page 1 RESPIRATORY
MEDICINE (2000) 94 (SWPLEMENT E), S6-SlO Pharmacology of bronchodilators used in the …

Chronic obstructive pulmonary disorder (COPD) is a term used to describe a range of
chronic airway disorders characterized by airflow limitation that is not fully reversible …

OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of
death in the United States and is estimated to be responsible for 119,000 deaths in the year …